Suspended

SASOVRRetinal Vein Occlusion and Obstructive Sleep Apnea: A Case Control Study

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Sleeping Monitor

Other
Who is being recruted

Apnea+14

+ Cardiovascular Diseases

+ Eye Diseases

Over 18 Years
See all eligibility criteria
How is the trial designed

Prevention Study

Interventional
Study Start: September 2021
See protocol details

Summary

Principal SponsorCentre Hospitalier Régional d'Orléans
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: September 1, 2021

Actual date on which the first participant was enrolled.

There will be two groups of 50 patients. One with Retinal Vein Occlusion, and the other one, with no Retinal Vein Occlusion will be chosen from the consultation. The compared group will be paired on different criteria including hypertension, ocular hypertension, diabetes, sex, age. They will all spend a night at home with a Sleeping Monitor (Nox T3) in order to evaluate if they have an Obstructive Sleep Apnea.

Official TitleRetinal Vein Occlusion and Obstructive Sleep Apnea: A Case Control Study
NCT04011358
Principal SponsorCentre Hospitalier Régional d'Orléans
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Prevention Study

Prevention studies aim to stop a disease from developing. They often involve people at risk and test things like vaccines, lifestyle changes, or preventive medications.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

ApneaCardiovascular DiseasesEye DiseasesNervous System DiseasesRespiration DisordersRespiratory Tract DiseasesRetinal DiseasesRetinal Vein OcclusionSleep Apnea SyndromesSleep Wake DisordersThrombosisVascular DiseasesEmbolism and ThrombosisSleep Apnea, ObstructiveVenous ThrombosisSleep Disorders, IntrinsicDyssomnias

Criteria

Inclusion Criteria: * All patients with an Retinal Vein Occlusion for one group (patients) * All patients with no Retinal Vein Occlusion for the other group (control) Non-inclusion Criteria: * minor * Severe Insomnia * Neuromuscular Disease with respiratory muscle impairment * Chronic opioid medication * Pregnancy women. * Patient under guardianship

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

2 intervention groups are designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Patient with Retinal Vein Occlusion

Group II

Patient with no Retinal Vein Occlusion

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

CHR d'Orléans

Orléans, FranceOpen CHR d'Orléans in Google Maps
SuspendedOne Study Center